CTI BioPharma Corp (CTIC) is higher by Friday morning, with the stock climbing 5.46% in pre-market trading to 3.86. CTIC's short-term technical score of 91 indicates that the stock has traded more bullishly over the last month than 91% of stocks on the market. In the Biotechnology industry, which ranks 132 out of 146 industries, CTI BioPharma Corp ranks higher than 98% of stocks. CTI BioPharma Corp has fallen 13.68% over the past month, closing at $4.34 on April 15. During this period of time, the stock fell as low as $3.55 and as high as $5.76. CTIC has an average analyst recommendation of Strong Buy. The company has an average price target of $7.55.
CTIC has an Overall Score of 89. Find out what this means to you and get the rest of the rankings on CTIC!